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Neuronal activity regulates cognition and neural stem cell (NSC) function. The molec‐
ular pathways limiting neuronal activity during aging remain largely unknown. In this 
work, we show that p38MAPK activity increases in neurons with age. By using mice 
expressing p38α‐lox and CamkII‐Cre alleles (p38α∆‐N), we demonstrate that genetic 
deletion of p38α in neurons suffices to reduce age‐associated elevation of p38MAPK 
activity, neuronal loss and cognitive decline. Moreover, aged p38α∆‐N mice present 
elevated numbers of NSCs in the hippocampus and the subventricular zone. These 
results reveal novel roles for neuronal p38MAPK in age‐associated NSC exhaustion 
and cognitive decline.
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1  | INTRODUC TION
Neurogenesis occurs in the subgranular zone of the dentate gyrus 
(DG) in the hippocampus and the subventricular zone (SVZ) of the 
lateral ventricle in the adult mammalian brain. Adult hippocampal 
neurogenesis arises from neural stem cells (NSCs) within the DG. 
NSCs give rise to intermediate progenitor cells, which divide gener‐
ating immature neurons that subsequently integrate into the local 
neural network as granule cells. Accumulating evidence suggests 
that adult‐born neurons may play distinct physiological roles in 
hippocampus‐dependent functions such as memory encoding and 
mood	regulation	(Goncalves,	Schafer,	&	Gage,	2016).	Age	induces	a	
decline in adult NSC activity and neuronal plasticity, which could par‐
tially explain some age‐related cognitive deficit symptoms (Capilla‐
Gonzalez,	 Herranz‐Perez,	 &	 Garcia‐Verdugo,	 2015;	 Encinas	 et	 al.,	
2011; Goncalves et al., 2016). Neuronal loss or dysfunction also con‐
tributes to the onset of age‐related neurodegenerative pathologies.
Increasing evidence reveals that NSC activity is regulated by in‐
trinsic and extrinsic factors. Among the latter, it has been recently 
shown that neuronal activity controls NSC quiescence and subse‐
quently neurogenesis in the hippocampus (Song et al., 2012; Yeh et 
al., 2018). The molecular mechanism by which neuronal activity con‐
tributes to the regulation of NSCs, and whether this decreases with 
aging, remains unknown.
p38 mitogen‐activated protein kinase (p38MAPK) is an important 
sensor of intrinsic and extrinsic stresses and consequently controls key 
processes of mammalian cell homeostasis such as self‐renewal, dif‐
ferentiation,	proliferation	and	death	(Cuadrado	&	Nebreda,	2010).	 In	
the brain, p38MAPK signalling is activated during neurodegenerative 
diseases and in response to brain injury (Hensley et al., 1999; Irving, 
Barone,	Reith,	Hadingham,	&	Parsons,	2000).	 Its	genetic	or	pharma‐
cological inhibition ameliorates symptoms of neurodegenerative dis‐
eases and protects against ischemia (Barone et al., 2001; Colie et al., 
2017;	Roy	et	al.,	2015).	There	is	evidence	that	p38MAPK	can	regulate	
some functions in neurons and NSCs during embryo development and 
postnatal	 stages	 (Cheng,	 Chan,	 Milhavet,	 Wang,	 &	 Mattson,	 2001;	
Hamanoue	 et	 al.,	 2016;	 Kummer,	 Rao,	 &	 Heidenreich,	 1997).	 The	
p38MAPK family comprises four members, with p38α and p38β being 
expressed at high levels in the brain. p38α has been involved in inflam‐
mation and environmental stresses, and there is evidence implicating 
p38α in neuronal function and cognitive activity with contradictory 
results	 (Cortez	 et	 al.,	 2017;	 Kase,	Otsu,	 Shimazaki,	 &	Okano,	 2019;	
Stefanoska	et	al.,	2018;	Xing,	Bachstetter,	&	Eldik,	2015).	In	this	study,	
we characterized the impact of genetic inactivation of p38α specifically 
in neurons during physiological aging.
2  | RESULTS
2.1 | p38MAPK activity in neurons increases with 
aging
We	 first	 determined	 the	 activity	 of	 p38MAPK	 in	CA1	 and	DG	 re‐
gions	of	hippocampus	in	young	(2‐month‐old)	and	aged	(≥2‐year‐old)	
C57BL/6J mice. Immunofluorescence showed that p38MAPK phos‐
phorylated in the activating residues (P‐p38MAPK) was absent or 
very low in the cells along the CA1 and DG from young mice but sig‐
nificantly increased in over 2‐year‐old animals (Figure 1a,b). Moreover, 
the expression of all p38MAPK family members (MAPK11 (β), MAPK12 
(γ), MAPK13 (δ) and MAPK14 (α)) was elevated in ex vivo analysis using 
hippocampal tissue obtained from aged mice (Figure 1c).
Long‐term cultured neurons in vitro share multiple characteris‐
tics	of	physiological	 aging	 (Lesuisse	&	Martin,	 2002).	We	cultured	
neurons harvested from cortex and hippocampus of mouse embryos 
and observed that cells maintained for longer periods (DIV9 and 
DIV21 vs. DIV3 and DIV8, respectively) contained higher levels of P‐
p38MAPK (Figure 1d,e). Moreover, the elevated P‐p38MAPK in neu‐
rons correlated with lower expression of the Tuj1 neuronal marker, 
loss of synapses and dendritic spines, and enhanced neuronal loss 
(Figure 1f–h), all characteristics of neuronal aging. These results re‐
veal that the activity of p38MAPK increases with age in neurons in 
vivo and in vitro.
2.2 | Genetic deletion of p38α in neurons prevents 
age‐associated neuronal loss and neuroinflammation
To characterize the function of p38MAPK in neuronal aging in vivo, 
mice expressing p38α‐lox and CamkII‐Cre alleles (p38α∆‐N), which 
specifically downregulate p38α	in	neurons	(Colie	et	al.,	2017),	were	
maintained for more than 2 years. Immunostaining analysis revealed 
reduced P‐p38MAPK+	cells	in	the	CA1	(4.15	±	1.38	vs.	7.31	±	0.44)	
and	DG	(25.71	±	18.23	vs.	56.06	±	6.97)	of	p38α∆‐N mice that were 
over 24‐month‐old compared to wt control (expressing p38α) mice 
of the same age (Figure 2a,b). This indicates that p38α is responsible 
for	≈50%	of	the	p38MAPK	activity	in	aged	neurons.	In	this	context,	
the number of cells expressing the mature neuron marker NeuN 
was	 increased	 in	 both	 regions	 by	 ≈40%,	 particularly	 in	 the	DG	of	
p38α∆‐N mice (Figure 2c,d).
p38MAPK is an important regulator of the central nervous sys‐
tem	 inflammatory	 responses	 (Bachstetter	 &	 Van	 Eldik,	 2010).	 To	
determine the effect of deletion of neuronal p38α on neuroinflam‐
mation, we first measured the expression of Iba‐1 and GFAP, mark‐
ers of microglia and astrocytes, respectively. Immunofluorescence 
showed no statistically significant differences in the number of Iba‐1+ 
and GFAP+ cells in the CA1 and DG areas between p38α∆‐N and wt 
mice (Figure 2e–h and Figure S1), although p38α∆‐N mice presented 
slightly higher GFAP+ cells in both regions, which correlated with in‐
creased levels of vimentin (Figure 2i). Next, we used an array to mea‐
sure the expression of a battery of 40 cytokines in the hippocampus 
of old mice, but no differences were detected in key pro‐inflamma‐
tory cytokines such as TNFα, IFNγ, IL6 or IL1α between p38α∆‐N 
and wt mice. However, we found some cytokines and chemokines 
differentially expressed, including CCL11 and CXCL1 that were 
reduced,	and	IL7,	IL17	and	CCL12	increased	in	p38α∆‐N mice com‐
pared with wt mice (Figure 2j). These data indicate that reduction 
in p38MAPK activity alters the expression of several cytokines and 
chemokines in the hippocampus.
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2.3 | Genetic deletion of p38α in neurons prevents 
age‐associated NSC exhaustion
Next, we characterized the population of NSCs in the hippocam‐
pus. First, we observed that the number of DG cells capable of 
forming	 neurospheres	 in	 vitro	was	 ≈30%	 higher	 in	p38α∆‐N than 
in wt mice at different ages (Figure 3a). Importantly, these results 
were corroborated in vivo where the number of SOX2+ and SOX9+ 
cells,	markers	of	quiescent	NSCs	 (Hutton	&	Pevny,	2011;	Scott	et	
al.,	2010;	Shin	et	al.,	2015),	was	elevated	by	30%	and	24%,	respec‐
tively, in p38α∆‐N mice that were over 24‐month‐old (Figure 3b,c). 
In line with this, NSCs expressing both SOX2 and GFAP were also 
higher	by	23%	in	p38α∆‐N mice (Figure 3d,e), whereas the numbers 
of intermediate progenitors SOX2+ and GFAP‐ were similar between 
F I G U R E  1   Increased p38MAPK activity in neurons with aging (a) Representative immunofluorescence for phosphorylated p38MAPK 
(P‐p38MAPK) in CA1 and DG of young (2‐month‐old) and aged (over 24‐month‐old) C57BL/6J mice (n = 2). (b) Quantification of P‐p38MAPK 
in these regions. (c) MAPK11, MAPK12, MAPK13 and MAPK14 mRNA levels in hippocampus of young and aged C57BL/6J mice (n	≥	4).	(d)	
P‐p38MAPK in DIV3 and DIV9 neurons harvested from cortex of C57BL/6J embryos (n = 3). (e) P‐p38MAPK and Tuj1 in DIV8 and DIV21 
neurons harvested from hippocampus from C57BL/6J embryos. Results representative of two independent experiments. (f) Representative 
immunofluorescence	of	Tuj1	staining	and	morphology	of	neurons	at	DIV3	and	DIV9.	(g)	Quantification	of	TUJ1	staining	at	indicated	time	
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p38α∆‐N and wt	 mice	 (Figure	 3d,e).	 Moreover,	 analysis	 of	 Ki67+ 
cells showed a marked decrease in proliferation in both genotypes 
with age, but still p38α∆‐N mice displayed increased proliferation 
in	young	(19.5%	vs.	16.57%)	as	well	as	 in	advanced	age	(1.57%	vs.	
0.55%)	 (Figure	3f,g).	Finally,	 the	staining	of	DCX,	marker	of	 imma‐
ture neurons, was twofold higher in aged p38α∆‐N mice (Figure 3h,i). 
Together, these data show that genetic deletion of p38α in neurons 
contributes to maintain NSC quiescence and delays the age‐associ‐
ated exhaustion of NSCs.
We	also	characterized	the	pool	of	NSCs	in	the	neurogenic	niche	
of the SVZ. Ex vivo, the ability of SVZ cells to form neurospheres 
was significantly higher in both young and aged p38α∆‐N mice com‐
pared with SVZ cells from wt mice of similar age (Figure 4a). Same 
results were obtained counting secondary neurospheres (Figure 4b), 
indicative of increased self‐renewal ability. This correlated with en‐
hanced differentiation capability, as neurospheres from p38α∆‐N 
mice gave rise to higher numbers of neurons and glial cells, measured 
by	immunofluorescence	of	TUJ1,	CNPase	and	GFAP	(Figure	4c).	 In	
vivo, the SVZ of aged p38α∆‐N mice displayed increased number of 
SOX2+ and SOX9+ cells (Figure 4d,e) as well as higher mRNA levels 
(≈2	fold	increase)	compared	to	the	SVZ	of	wt mice of the same age 
(Figure	4f).	Moreover,	Ki67	staining	showed	decreased	proliferating	
cells on both genotypes with aging, but p38α∆‐N mice presented a 
higher	number	of	Ki67+	cells	 (17%	in	young	and	28%	in	aged)	than	
wt mice (Figure 4g,h). Taken together, our results identify a role for 
neuronal p38α in the decline of NSC activity in both DG and SVZ 
with aging.
2.4 | Genetic deletion of p38α in neurons delays 
cognitive decline
Finally, we investigated whether the cellular effects observed upon 
neuronal deletion of p38α could be translated at the brain functional 
level. Therefore, we carried out several cognitive and noncognitive 
tests. First, we performed T‐maze, openfield and novel objective 
recognition tests, which have been associated with hippocampal 
activities of memory, learning, locomotion, anxiety and exploratory 
behaviour, and are known to deteriorate with aging (Gage, Dunnett, 
&	Bjorklund,	1984;	Lamberty	&	Gower,	1992;	Shoji,	Takao,	Hattori,	
&	Miyakawa,	2016).	Specifically,	when	comparing	those	tests	in	aged	
mice, p38α∆‐N mice performed better than wt mice in T‐maze cor‐
rect rate, with the correct choice percentages of p38α∆‐N mice being 
significantly higher than those of wt mice at 10‐ and 40‐s delay time 
(Figure 5a). In addition, the time required for correct choice was also 
reduced in p38α∆‐N	mice	(Figure	S2a).	We	also	detected	differences	
in the openfield test, with p38α∆‐N mice covering higher distance, 
with elevated average speed and resting less time in both central 
and peripheral areas (Figure 5b, c and Figure S2b). In the novel object 
recognition test, we observed no differences in discrimination index, 
although p38α∆‐N mice spent more time exploring both objects 
(Figure S2c). In contrast, we did not find differences in grip strength 
or body weight between aged p38α∆‐N mice and wt mice (Figure 5d, 
e), suggesting that the observed phenotypes are mostly dependent 
on improved cognitive activity rather than motor skills. To further 
confirm this idea, we performed two additional cognition tests, hole 
board and tightrope, which are known to deteriorate with aging and, 
at least the former, measures specific cognitive functions of neo‐
philia and/or anxiety‐like behaviour (Carrasco‐Garcia, Arrizabalaga, 
Serrano,	Lovell‐Badge,	&	Matheu,	2015;	Lamberty	&	Gower,	1992).	
Aged p38α∆‐N mice displayed increased head‐dipping frequency 
(21.5 vs. 14.2 in wt mice) in the hole‐board test (Figure 5f). Moreover, 
the tightrope neuromuscular test performance was also significantly 
improved in aged p38α∆‐N	mice	with	70%	succeeding	it	compared	to	
only	20%	of	wt mice (Figure 5g). These results reveal that inhibition 
of p38MAPK activity in neurons helps to maintain cognitive activity 
in aged mice.
3  | DISCUSSION
Our results show that neuronal p38MAPK activity increases with 
aging both in neuronal cultures ex vivo and in the hippocampus in 
vivo, and this elevation is deleterious for neuronal function. Indeed, 
genetic inactivation of p38α specifically in neurons, using mice ex‐
pressing p38α‐lox and CamkII‐Cre alleles, ameliorates age‐associated 
neuronal loss in the hippocampus. It bears mention that the DG 
followed by CA1 and CA3 layers of the hippocampus are the brain 
regions where CaMKIIα	is	most	abundantly	expressed	(Dragatsis	&	
Zeitlin,	2000;	Wang,	Zhang,	Szabo,	&	Sun,	2013).	In	particular,	over	
70%	of	 granular	 neurons	 in	 the	DG	and	pyramidal	 neurons	 in	 the	
CA1 and C3, as well as mossy neurons, strongly express CaMKIIα 
(Wang	et	al.,	2013).	Thus,	our	results	show	that	genetic	deletion	of	
p38α in the majority of neurons in the hippocampus prevents age‐
associated neuronal loss, but we cannot rule out that p38α deletion 
could also take place in additional brain areas where CaMKIIα is ex‐
pressed	with	lower	intensity	(Wang	et	al.,	2013).
Our study also reveals that p38α∆‐N mice present elevated 
cell proliferation levels not only in the DG of the hippocampus but 
also in the SVZ in young and importantly in aged mice. Moreover, 
aged p38α∆‐N mice maintain higher number of quiescent NSCs 
as well as of intermediate progenitor cells and neuroblasts. Thus, 
our data indicate an age‐dependent role for neuronal p38α in 
F I G U R E  2   Genetic deletion of p38α in neurons prevents age‐associated neuronal loss (a, b) Representative immunofluorescence and 
quantification for phosphorylated p38MAPK (P‐p38MAPK) relative to DAPI in (a) CA1 and (b) DG of aged (over 24‐month‐old) wt and 
p38α∆‐N mice (n	≥	4).	(c,	d)	Immunofluorescence	and	quantification	for	NeuN+ cells in (c) CA1 and (d) DG of aged wt and p38α∆‐N mice 
(n	≥	4).	(e,	f)	Immunofluorescence	and	quantification	for	Iba‐1+ cells in (e) CA1 and (f) DG of aged wt and p38α∆‐N mice (n	≥	4).	(e,	f).	(g,	
h) Immunofluorescence and quantification for GFAP+ cells in (g) CA1 and (h) DG of aged wt and p38α∆‐N mice (n	≥	4).	(i).	Immunoblot	of	
vimentin from ex vivo hippocampal tissue from wt and p38α∆‐N aged mice (n = 2). (j) Quantification of differentially expressed cytokines in 
ex vivo hippocampal tissue from aged wt and p38α∆ mice (n = 2)
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regulating NSC exhaustion and regenerative decline in the aging 
brain. This is in line with our in vitro neurosphere studies showing 
that aged p38α∆‐N NSCs maintain enhanced self‐renewal and dif‐
ferentiation potential. It is possible to surmise that age‐associated 
upregulation of neuronal p38α expression, and hence enhanced 
p38MAPK activity, induces NSC exhaustion (a) promoting niche 
deterioration that requires NSC activation and proliferation, and 
hence their exhaustion at advanced ages, and (b) failing to send 
proper signals to NSCs, and thereby affecting cell fate decisions. 
Both	options	have	been	described	in	different	contexts	(Schultz	&	
Sinclair, 2016).
In support of this idea, we detected differential expression of 
some cytokines and chemokines in the hippocampus. Specifically, 
aged p38α∆‐N	mice	displayed	higher	 levels	 of	 IL7,	 a	 cytokine	 that	
promotes	 neuronal	 survival	 (Michaelson,	 Mehler,	 Xu,	 Gross,	 &	
Kessler, 1996), and decreased levels of the chemokines CCL11 and 
CXCL1, whose elevation has been associated with systemic aging, 
and their high levels are detrimental to neurogenesis and cogni‐
tive function, particularly in the case of CCL11 (Villeda et al., 2011; 
Wolfe,	Minogue,	 Rooney,	 &	 Lynch,	 2018).	Moreover,	 we	 also	 de‐
tected higher VIMENTINE levels, which are associated with astro‐
cyte	activation	and	mobilization	(Liu	et	al.,	2014;	Wilhelmsson	et	al.,	
F I G U R E  3   Genetic deletion of p38α in neurons prevents NSC exhaustion in the hippocampus (a) Quantification of neurospheres from 
DG of wt and p38α∆‐N mice (n = 3). (b, c) Representative immunofluorescence and quantification of SOX2 and SOX9 in the DG of aged mice 
(n	≥	4).	(d,	e)	Representative	images	and	quantification	of	SOX2	(green)	and	GFAP	(yellow)	in	DG	of	aged	mice	(n	≥	6).	(f,	g)	Representative	
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2019). Thus, the positive impact of p38α deletion, and consequent 
reduction in p38MAPK activity, in neurons is likely mediated by con‐
trolling the neuroinflammatory status of the niche. This is consistent 
with the role of p38MAPK pathway, and in particular p38α, as in‐
flammatory	mediator	in	the	central	nervous	system	(Bachstetter	&	
Van Eldik, 2010). Future studies should provide additional informa‐
tion on the specific neurons that are responsible for the phenotypes 
identified in p38α∆‐N mice.
We	 have	 previously	 shown	 that	 adult	 p38α∆‐N mice are 
healthy and are indistinguishable from wt littermates, also in terms 
F I G U R E  4   Genetic deletion of p38α in neurons prevents NSC exhaustion in the SVZ (a, b) Quantification of primary and secondary 
neurospheres from SVZ of wt and p38α∆‐N mice at different ages (n	=	6).	(c)	Representative	immunofluorescence	of	TUJ1,	GFAP	and	
CNPase derived from aged neurospheres of wt and p38α∆‐N	mice	differentiated	in	the	absence	of	growth	factors	and	1%	of	serum	(n = 3). 
(d, e) Representative images of SOX9 and SOX2 NSC markers in the SVZ of wt and p38α∆‐N mice at indicated ages (n	≥	3).	(f)	mRNA	levels	
of Sox2 and Sox9 in the SVZ of aged wt and p38α∆‐N mice (n	=	4).	(g,	h)	Representative	images	and	quantification	of	Ki67+ cells in young and 
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of cognitive behaviour, based on the performance of novel object 
recognition	test	(Colie	et	al.,	2017).	In	advanced	age,	T‐maze	and	
open‐field tests reveal improved spatial working memory and en‐
hanced locomotor activity in aged p38α∆‐N mice. Thus, deletion 
of p38α in neurons is sufficient to delay the age‐associated decline 
of hippocampal‐specific cognitive activities. In line with this idea, 
middle‐aged mice systemically expressing a p38αAF dominant‐neg‐
ative mutant present improved context fear discrimination task, 
although they do not show improvements in additional cognitive 
activities such as memory, exploratory behaviour or locomotion 
(Cortez	et	al.,	2017).	Together,	these	results	show	the	requirement	
of increasing age for the deleterious action of p38MAPK elevation 
in brain homeostasis and cognitive activity in the hippocampus. 
Moreover, the improved performance of p38α∆‐N mice in hole‐
board and neuromuscular coordination tests further highlights the 
role that the p38MAPK pathway, and p38α in particular, exert in 
maintaining cognitive functions.
In summary, our results reveal an unprecedented function of 
p38MAPK regulating neuronal activity to reduce NSC function 
with aging. Moreover, they support recent studies showing that 
different neuronal types and neuronal activities control NSC 
quiescence at adult stage (Song et al., 2012; Yeh et al., 2018) and 
extend this idea to physiological aging. Ultimately, our data provide 
experimental evidence supporting the pharmacological targeting 
of p38MAPK for therapy against age‐associated cognitive decline.
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